Description GHK-cu / KPV Blend 50mg/20mg Research-Grade Compound GHK-cu / KPV Blend 50mg/20mg is a research-grade compound supplied in a sterile sealed vial, intended strictly for use in controlled laboratory environments
Previous WHO recommendations focused on the latter
Pickart L (2015)
Animal experiments confirmed that dural injection of bone marrow mesenchymal stem cell-derived exosomes miR-367-3p significantly reduced the expression of EZH2 in spinal cord tissues of EAE mice, increased the expression of SLC7A11, GPX4, GSH, and SOD, decreased the levels of Fe 2+ and MDA, inhibited spinal cord iron deposition, ferroptosis, and inflammation, and alleviated spinal cord injury ( 2+ and MDA levels, while reducing GSH, NRF2, and GPX4 expression, as well as iron reactive element binding protein 2 (IREB2) in optic nerve tissue
Li ZJ, Choi H-I, Choi D-K, Sohn K-C, Im M, Seo Y-J, Lee Y-H, Lee J-H, Lee Y
In June, Arkansas filed a similar lawsuit